Table: Hisamitsu - 6-MTH group results
Oct 14 (Reuters)-
Hisamitsu Pharmaceutical Co Inc
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
6 months ended 6 months ended Year to
Aug 31, 2021 Aug 31, 2020 Feb 28, 2022
LATEST YEAR-AGO LATEST
RESULTS RESULTS FORECAST
Sales 58.55 52.93 122.90
(+10.6 pct) (-16.5 pct) (+7.3 pct)
Operating 5.71 5.52 10.70
(+3.5 pct) (-45.9 pct) (+0.3 pct)
Recurring 6.84 5.52 12.70
(+23.9 pct) (-48.1 pct) (+7.4 pct)
Net 5.00 3.69 9.90
(+35.4 pct) (-51.1 pct) (+7.0 pct)
EPS 61.20 yen 45.22 yen 121.12 yen
EPS Diluted 61.16 yen 45.16 yen
Ann Div 83.50 yen 84.00 yen
-Q2 div 42.00 yen 41.75 yen
-Q4 div 41.75 yen 42.00 yen
NOTE - Hisamitsu Pharmaceutical Co Inc.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4530.T
Recent news on Hisamitsu Pharmaceutical Co
See all newsTable: Hisamitsu -2025/26 group results
Table: Hisamitsu -2025/26 parent results
Brief: Hisamitsu Pharmaceutical Co Inc - To Retire Treasury Shares Worth 6.34% Of Outstanding Stock On May 12
Brief: Hisamitsu Pharmaceutical Co Inc - Tender Offer Of Company By Taiyo Kosan Successfully Completed
Japan's Hisamitsu Pharmaceutical plans $2.55 billion MBO